Data highlights symptom stability and enhanced efficacy signals in higher dose group –– Analysis offers valuable insights to guide ongoing ...
Stockhead on MSN
Alterity delivers encouraging phase II data in MSA trial
Alterity has presented promising phase II trial data of lead compound ATH434 in multiple system atrophy at an international ...
Emory researchers reveal a strong link between mental health and heart disease, showing some disorders can raise heart risks by up to 100%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback